Skip to main content
Clinical Trials/ITMCTR2200005999
ITMCTR2200005999
Recruiting
Phase 1

Molecular epidemiological analysis of prostate cancer in Hunan population and research on the intervention of warming the kidney and promoting blood circulation and detoxification

the First Affiliated Hospital of Hunan University of Chinese Medicine0 sitesTBD
Conditionsprostate cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
prostate cancer
Sponsor
the First Affiliated Hospital of Hunan University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Epidemilogical research
Sex
Male

Investigators

Sponsor
the First Affiliated Hospital of Hunan University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • Patients with undetermined or unknown prostate dynamic tumors requiring prostate needle biopsy. ? Suspicious prostate nodules on digital rectal examination, any prostate\-specific antigen values; ? Transrectal prostate ultrasound or MRI found suspicious lesions with normal prostate\-specific antigen; ? Prostate specific antigen \> 10 ng/ mL; ? Prostate\-specific antigen was 4\-10 ng/ mL, and free prostate\-specific antigen/total free prostate\-specific antibody (fPSA/tPSA) was suspicious. Patients in line with the first two criteria should undergo prostate puncture biopsy regardless of the value of psa.

Exclusion Criteria

  • ? Patients who have been diagnosed with prostate cancer; ? Patients with serious heart, brain, liver and kidney diseases and intolerance to prostate biopsy; ? Those who are unwilling to receive needle biopsy of prostate.

Outcomes

Primary Outcomes

Not specified

Similar Trials